Upgrade to SI Premium - Free Trial

FibroGen (FGEN) Posts Large Q2 EPS, Rev Beat

August 8, 2019 5:00 PM
FibroGen (NASDAQ: FGEN) reported Q2 EPS of $1.26, $1.77 better than the analyst estimate of ($0.51). Revenue for the quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Earnings

Next Articles